Summary
- Hong Kong Investment Corporation partners with Biomap, a biotech firm founded by Baidu’s Robin Li Yanhong
- Biomap will set up an accelerator to support over 50 early-stage R&D projects in life science, with a focus on projects recommended by Hong Kong universities
- Hong Kong aims to accelerate development in bio computing to gain a first-mover advantage
- HKIC is leading Biomap’s current financing round, setting parameters and terms for other investors
